// App-Quantinova.ai

15394 2014 AHA : Novel Apolipoprotein E-derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport in vitro and Induces de novo Formation of Apoa-I Containing pre?-1 HDL in Human Plasma

Researchers

Presenter

  • John K Bielicki

Principal Investigators

  • Jan O Johansson

  • Jacques Genest

Medical Centers

  • Univ of California, California, CA

  • McGill, Montreal, QC, Canada

  • Artery Therapeutics, San Ramon, CA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

Biomarkers

  • Cholesterol

Drug/Treatment

  • Choline bitartrate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved